ivabradine has been researched along with lisinopril in 1 studies
Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (lisinopril) | Trials (lisinopril) | Recent Studies (post-2010) (lisinopril) |
---|---|---|---|---|---|
1,143 | 197 | 833 | 2,210 | 648 | 491 |
Protein | Taxonomy | ivabradine (IC50) | lisinopril (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Homo sapiens (human) | 0.0021 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.287 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0012 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.0012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Gregorio, C; Ferraro, G; Potenza, G | 1 |
1 other study(ies) available for ivabradine and lisinopril
Article | Year |
---|---|
Effectiveness of the combination therapy with lisinopril, ivabradine and multivitamin supplementation in anthracycline-induced severe cardiotoxicity.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Benzazepines; Cardiotoxicity; Dietary Supplements; Drug Therapy, Combination; Female; Humans; Ivabradine; Lisinopril; Middle Aged; Treatment Outcome; Ventricular Dysfunction, Left; Vitamins | 2014 |